🇺🇸 GSK plcGLAXF
Get GSK plc filings on Telegram the moment they are published.
Follow GSK plc on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 6-K — Foreign issuer report
Overview: The US FDA has approved Hibsago (bepirovirsen) for treating chronic hepatitis B in adults without cirrhosis in combination with NrtI therapy.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest